Sionillo, Perla P.
HRN: 21-53-35 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/20/2022
MUPIROCIN 2%, 15G (TUBE)
07/20/2022
07/27/2022
TOPICA
2%
TID
Pressure Ulcer
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes